nodes	percent_of_prediction	percent_of_DWPC	metapath
Naltrexone—ABCB1—ulcerative colitis	0.501	1	CbGaD
Naltrexone—ABCB1—Methylprednisolone—ulcerative colitis	0.036	0.257	CbGbCtD
Naltrexone—ABCB1—Betamethasone—ulcerative colitis	0.0234	0.167	CbGbCtD
Naltrexone—ABCB1—Prednisolone—ulcerative colitis	0.0231	0.165	CbGbCtD
Naltrexone—ABCB1—Hydrocortisone—ulcerative colitis	0.0219	0.157	CbGbCtD
Naltrexone—ABCB1—Prednisone—ulcerative colitis	0.0218	0.156	CbGbCtD
Naltrexone—ABCB1—Dexamethasone—ulcerative colitis	0.0136	0.0974	CbGbCtD
Naltrexone—Naloxone—TLR4—ulcerative colitis	0.00351	0.586	CrCbGaD
Naltrexone—Hydromorphone—PTGS1—ulcerative colitis	0.000853	0.143	CrCbGaD
Naltrexone—Naloxone—ALB—ulcerative colitis	0.000438	0.0731	CrCbGaD
Naltrexone—Buprenorphine—ABCB1—ulcerative colitis	0.000421	0.0703	CrCbGaD
Naltrexone—Naloxone—ABCB1—ulcerative colitis	0.000418	0.0698	CrCbGaD
Naltrexone—Morphine—ABCB1—ulcerative colitis	0.000353	0.0589	CrCbGaD
Naltrexone—OPRK1—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.000192	0.0041	CbGpPWpGaD
Naltrexone—OPRM1—Peptide ligand-binding receptors—GHRL—ulcerative colitis	0.00019	0.00405	CbGpPWpGaD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.000188	0.00402	CbGpPWpGaD
Naltrexone—OPRD1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.000187	0.004	CbGpPWpGaD
Naltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000187	0.00399	CbGpPWpGaD
Naltrexone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000185	0.00394	CbGpPWpGaD
Naltrexone—OPRM1—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.000184	0.00393	CbGpPWpGaD
Naltrexone—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	0.00018	0.00384	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—IL12B—ulcerative colitis	0.000179	0.00383	CbGpPWpGaD
Naltrexone—OPRD1—GPCR ligand binding—CXCR2—ulcerative colitis	0.000172	0.00368	CbGpPWpGaD
Naltrexone—OPRD1—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000172	0.00367	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—CCL20—ulcerative colitis	0.00017	0.00362	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—CTLA4—ulcerative colitis	0.000169	0.0036	CbGpPWpGaD
Naltrexone—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	0.000168	0.00358	CbGpPWpGaD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.000168	0.00358	CbGpPWpGaD
Naltrexone—OPRD1—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000166	0.00354	CbGpPWpGaD
Naltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.000164	0.00351	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—CXCR1—ulcerative colitis	0.000163	0.00349	CbGpPWpGaD
Naltrexone—OPRM1—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.000162	0.00346	CbGpPWpGaD
Naltrexone—OPRD1—GPCR ligand binding—CCR6—ulcerative colitis	0.000162	0.00346	CbGpPWpGaD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000158	0.00337	CbGpPWpGaD
Naltrexone—Asthenia—Mesalazine—ulcerative colitis	0.000153	0.000499	CcSEcCtD
Naltrexone—Shock—Prednisolone—ulcerative colitis	0.000153	0.000498	CcSEcCtD
Naltrexone—Cough—Triamcinolone—ulcerative colitis	0.000153	0.000498	CcSEcCtD
Naltrexone—Oedema—Hydrocortisone—ulcerative colitis	0.000152	0.000495	CcSEcCtD
Naltrexone—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.000152	0.000495	CcSEcCtD
Naltrexone—OPRD1—G alpha (i) signalling events—ADCY5—ulcerative colitis	0.000152	0.00324	CbGpPWpGaD
Naltrexone—Convulsion—Triamcinolone—ulcerative colitis	0.000152	0.000495	CcSEcCtD
Naltrexone—Tachycardia—Prednisolone—ulcerative colitis	0.000152	0.000494	CcSEcCtD
Naltrexone—Convulsion—Methylprednisolone—ulcerative colitis	0.000151	0.000493	CcSEcCtD
Naltrexone—OPRK1—GPCR ligand binding—CXCR2—ulcerative colitis	0.000151	0.00323	CbGpPWpGaD
Naltrexone—Hypertension—Triamcinolone—ulcerative colitis	0.000151	0.000493	CcSEcCtD
Naltrexone—Pruritus—Mesalazine—ulcerative colitis	0.000151	0.000492	CcSEcCtD
Naltrexone—Hypertension—Methylprednisolone—ulcerative colitis	0.000151	0.000492	CcSEcCtD
Naltrexone—Infection—Hydrocortisone—ulcerative colitis	0.000151	0.000491	CcSEcCtD
Naltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.00015	0.00321	CbGpPWpGaD
Naltrexone—Hyperhidrosis—Prednisolone—ulcerative colitis	0.00015	0.00049	CcSEcCtD
Naltrexone—Shock—Hydrocortisone—ulcerative colitis	0.000149	0.000487	CcSEcCtD
Naltrexone—Myalgia—Triamcinolone—ulcerative colitis	0.000149	0.000486	CcSEcCtD
Naltrexone—Vomiting—Azathioprine—ulcerative colitis	0.000149	0.000486	CcSEcCtD
Naltrexone—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000149	0.000485	CcSEcCtD
Naltrexone—Myalgia—Methylprednisolone—ulcerative colitis	0.000149	0.000485	CcSEcCtD
Naltrexone—Arthralgia—Methylprednisolone—ulcerative colitis	0.000149	0.000485	CcSEcCtD
Naltrexone—ABCB1—Allograft Rejection—HLA-DQA1—ulcerative colitis	0.000149	0.00317	CbGpPWpGaD
Naltrexone—Eye disorder—Prednisone—ulcerative colitis	0.000148	0.000484	CcSEcCtD
Naltrexone—Anxiety—Methylprednisolone—ulcerative colitis	0.000148	0.000483	CcSEcCtD
Naltrexone—Tachycardia—Hydrocortisone—ulcerative colitis	0.000148	0.000483	CcSEcCtD
Naltrexone—Rash—Azathioprine—ulcerative colitis	0.000148	0.000482	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000148	0.000482	CcSEcCtD
Naltrexone—Dermatitis—Azathioprine—ulcerative colitis	0.000147	0.000481	CcSEcCtD
Naltrexone—Skin disorder—Hydrocortisone—ulcerative colitis	0.000147	0.000481	CcSEcCtD
Naltrexone—Ill-defined disorder—Dexamethasone—ulcerative colitis	0.000147	0.000481	CcSEcCtD
Naltrexone—Ill-defined disorder—Betamethasone—ulcerative colitis	0.000147	0.000481	CcSEcCtD
Naltrexone—Discomfort—Triamcinolone—ulcerative colitis	0.000147	0.00048	CcSEcCtD
Naltrexone—Discomfort—Methylprednisolone—ulcerative colitis	0.000147	0.000479	CcSEcCtD
Naltrexone—Headache—Azathioprine—ulcerative colitis	0.000147	0.000478	CcSEcCtD
Naltrexone—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.000147	0.000478	CcSEcCtD
Naltrexone—OPRM1—TCR Signaling Pathway—RELA—ulcerative colitis	0.000146	0.00312	CbGpPWpGaD
Naltrexone—Diarrhoea—Mesalazine—ulcerative colitis	0.000146	0.000476	CcSEcCtD
Naltrexone—Dry mouth—Triamcinolone—ulcerative colitis	0.000146	0.000475	CcSEcCtD
Naltrexone—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000145	0.00311	CbGpPWpGaD
Naltrexone—Angioedema—Betamethasone—ulcerative colitis	0.000145	0.000473	CcSEcCtD
Naltrexone—Angioedema—Dexamethasone—ulcerative colitis	0.000145	0.000473	CcSEcCtD
Naltrexone—Anorexia—Hydrocortisone—ulcerative colitis	0.000145	0.000472	CcSEcCtD
Naltrexone—Angiopathy—Prednisone—ulcerative colitis	0.000144	0.00047	CcSEcCtD
Naltrexone—Confusional state—Methylprednisolone—ulcerative colitis	0.000144	0.000469	CcSEcCtD
Naltrexone—Immune system disorder—Prednisone—ulcerative colitis	0.000143	0.000468	CcSEcCtD
Naltrexone—OPRM1—GPCR ligand binding—CCL20—ulcerative colitis	0.000143	0.00306	CbGpPWpGaD
Naltrexone—Malaise—Betamethasone—ulcerative colitis	0.000143	0.000467	CcSEcCtD
Naltrexone—Malaise—Dexamethasone—ulcerative colitis	0.000143	0.000467	CcSEcCtD
Naltrexone—OPRM1—TCR Signaling Pathway—CD4—ulcerative colitis	0.000143	0.00306	CbGpPWpGaD
Naltrexone—Oedema—Triamcinolone—ulcerative colitis	0.000143	0.000466	CcSEcCtD
Naltrexone—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.000143	0.000466	CcSEcCtD
Naltrexone—OPRD1—GPCR ligand binding—PTGER4—ulcerative colitis	0.000143	0.00305	CbGpPWpGaD
Naltrexone—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.000142	0.000465	CcSEcCtD
Naltrexone—Syncope—Betamethasone—ulcerative colitis	0.000142	0.000464	CcSEcCtD
Naltrexone—Syncope—Dexamethasone—ulcerative colitis	0.000142	0.000464	CcSEcCtD
Naltrexone—OPRK1—GPCR ligand binding—CCR6—ulcerative colitis	0.000142	0.00304	CbGpPWpGaD
Naltrexone—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.000142	0.00303	CbGpPWpGaD
Naltrexone—Infection—Triamcinolone—ulcerative colitis	0.000142	0.000463	CcSEcCtD
Naltrexone—Infection—Methylprednisolone—ulcerative colitis	0.000142	0.000462	CcSEcCtD
Naltrexone—Dizziness—Mesalazine—ulcerative colitis	0.000141	0.00046	CcSEcCtD
Naltrexone—Shock—Triamcinolone—ulcerative colitis	0.00014	0.000458	CcSEcCtD
Naltrexone—Insomnia—Prednisolone—ulcerative colitis	0.00014	0.000458	CcSEcCtD
Naltrexone—Alopecia—Prednisone—ulcerative colitis	0.00014	0.000458	CcSEcCtD
Naltrexone—Shock—Methylprednisolone—ulcerative colitis	0.00014	0.000457	CcSEcCtD
Naltrexone—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.00014	0.000456	CcSEcCtD
Naltrexone—Loss of consciousness—Betamethasone—ulcerative colitis	0.00014	0.000455	CcSEcCtD
Naltrexone—Loss of consciousness—Dexamethasone—ulcerative colitis	0.00014	0.000455	CcSEcCtD
Naltrexone—Paraesthesia—Prednisolone—ulcerative colitis	0.000139	0.000455	CcSEcCtD
Naltrexone—Tachycardia—Triamcinolone—ulcerative colitis	0.000139	0.000455	CcSEcCtD
Naltrexone—Mental disorder—Prednisone—ulcerative colitis	0.000139	0.000454	CcSEcCtD
Naltrexone—Nausea—Azathioprine—ulcerative colitis	0.000139	0.000454	CcSEcCtD
Naltrexone—Tachycardia—Methylprednisolone—ulcerative colitis	0.000139	0.000454	CcSEcCtD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.000139	0.00297	CbGpPWpGaD
Naltrexone—Skin disorder—Methylprednisolone—ulcerative colitis	0.000138	0.000451	CcSEcCtD
Naltrexone—Malnutrition—Prednisone—ulcerative colitis	0.000138	0.000451	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000138	0.000451	CcSEcCtD
Naltrexone—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000138	0.00045	CcSEcCtD
Naltrexone—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.000138	0.000449	CcSEcCtD
Naltrexone—Convulsion—Dexamethasone—ulcerative colitis	0.000138	0.000449	CcSEcCtD
Naltrexone—Convulsion—Betamethasone—ulcerative colitis	0.000138	0.000449	CcSEcCtD
Naltrexone—Insomnia—Hydrocortisone—ulcerative colitis	0.000137	0.000447	CcSEcCtD
Naltrexone—Hypertension—Betamethasone—ulcerative colitis	0.000137	0.000447	CcSEcCtD
Naltrexone—Hypertension—Dexamethasone—ulcerative colitis	0.000137	0.000447	CcSEcCtD
Naltrexone—Paraesthesia—Hydrocortisone—ulcerative colitis	0.000136	0.000444	CcSEcCtD
Naltrexone—Vomiting—Mesalazine—ulcerative colitis	0.000136	0.000442	CcSEcCtD
Naltrexone—Myalgia—Dexamethasone—ulcerative colitis	0.000135	0.000441	CcSEcCtD
Naltrexone—Myalgia—Betamethasone—ulcerative colitis	0.000135	0.000441	CcSEcCtD
Naltrexone—Anxiety—Betamethasone—ulcerative colitis	0.000135	0.000439	CcSEcCtD
Naltrexone—Anxiety—Dexamethasone—ulcerative colitis	0.000135	0.000439	CcSEcCtD
Naltrexone—Rash—Mesalazine—ulcerative colitis	0.000134	0.000439	CcSEcCtD
Naltrexone—Dermatitis—Mesalazine—ulcerative colitis	0.000134	0.000438	CcSEcCtD
Naltrexone—Headache—Mesalazine—ulcerative colitis	0.000134	0.000436	CcSEcCtD
Naltrexone—Discomfort—Dexamethasone—ulcerative colitis	0.000134	0.000436	CcSEcCtD
Naltrexone—Discomfort—Betamethasone—ulcerative colitis	0.000134	0.000436	CcSEcCtD
Naltrexone—OPRK1—G alpha (i) signalling events—ADCY5—ulcerative colitis	0.000133	0.00284	CbGpPWpGaD
Naltrexone—Pain—Prednisolone—ulcerative colitis	0.000133	0.000433	CcSEcCtD
Naltrexone—OPRM1—TCR Signaling Pathway—IL1B—ulcerative colitis	0.000132	0.00282	CbGpPWpGaD
Naltrexone—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000132	0.00043	CcSEcCtD
Naltrexone—ABCB1—Allograft Rejection—IL10—ulcerative colitis	0.000131	0.0028	CbGpPWpGaD
Naltrexone—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000131	0.000427	CcSEcCtD
Naltrexone—Fatigue—Hydrocortisone—ulcerative colitis	0.000131	0.000427	CcSEcCtD
Naltrexone—OPRD1—GPCR ligand binding—GHRL—ulcerative colitis	0.000131	0.00279	CbGpPWpGaD
Naltrexone—Vision blurred—Prednisone—ulcerative colitis	0.00013	0.000425	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.00013	0.000424	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.00013	0.000423	CcSEcCtD
Naltrexone—Pain—Hydrocortisone—ulcerative colitis	0.00013	0.000423	CcSEcCtD
Naltrexone—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.00013	0.000423	CcSEcCtD
Naltrexone—Oedema—Betamethasone—ulcerative colitis	0.00013	0.000423	CcSEcCtD
Naltrexone—Anaphylactic shock—Betamethasone—ulcerative colitis	0.00013	0.000423	CcSEcCtD
Naltrexone—Oedema—Dexamethasone—ulcerative colitis	0.00013	0.000423	CcSEcCtD
Naltrexone—Insomnia—Triamcinolone—ulcerative colitis	0.000129	0.000421	CcSEcCtD
Naltrexone—Insomnia—Methylprednisolone—ulcerative colitis	0.000129	0.00042	CcSEcCtD
Naltrexone—Infection—Dexamethasone—ulcerative colitis	0.000129	0.00042	CcSEcCtD
Naltrexone—Infection—Betamethasone—ulcerative colitis	0.000129	0.00042	CcSEcCtD
Naltrexone—Ill-defined disorder—Prednisone—ulcerative colitis	0.000128	0.000418	CcSEcCtD
Naltrexone—Paraesthesia—Triamcinolone—ulcerative colitis	0.000128	0.000418	CcSEcCtD
Naltrexone—Feeling abnormal—Prednisolone—ulcerative colitis	0.000128	0.000417	CcSEcCtD
Naltrexone—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000128	0.000417	CcSEcCtD
Naltrexone—OPRM1—GPCR ligand binding—CXCR2—ulcerative colitis	0.000128	0.00273	CbGpPWpGaD
Naltrexone—Shock—Betamethasone—ulcerative colitis	0.000127	0.000416	CcSEcCtD
Naltrexone—Shock—Dexamethasone—ulcerative colitis	0.000127	0.000416	CcSEcCtD
Naltrexone—Dyspnoea—Triamcinolone—ulcerative colitis	0.000127	0.000415	CcSEcCtD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000127	0.00272	CbGpPWpGaD
Naltrexone—Nervous system disorder—Betamethasone—ulcerative colitis	0.000127	0.000415	CcSEcCtD
Naltrexone—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000127	0.000415	CcSEcCtD
Naltrexone—Agitation—Prednisone—ulcerative colitis	0.000127	0.000414	CcSEcCtD
Naltrexone—Nausea—Mesalazine—ulcerative colitis	0.000127	0.000413	CcSEcCtD
Naltrexone—Tachycardia—Betamethasone—ulcerative colitis	0.000126	0.000413	CcSEcCtD
Naltrexone—Tachycardia—Dexamethasone—ulcerative colitis	0.000126	0.000413	CcSEcCtD
Naltrexone—Angioedema—Prednisone—ulcerative colitis	0.000126	0.000412	CcSEcCtD
Naltrexone—ABCB1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000125	0.00268	CbGpPWpGaD
Naltrexone—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.000125	0.000409	CcSEcCtD
Naltrexone—Hyperhidrosis—Betamethasone—ulcerative colitis	0.000125	0.000409	CcSEcCtD
Naltrexone—OPRK1—GPCR ligand binding—PTGER4—ulcerative colitis	0.000125	0.00267	CbGpPWpGaD
Naltrexone—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.000125	0.000408	CcSEcCtD
Naltrexone—Malaise—Prednisone—ulcerative colitis	0.000125	0.000407	CcSEcCtD
Naltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.000125	0.00266	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000125	0.00266	CbGpPWpGaD
Naltrexone—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000124	0.000405	CcSEcCtD
Naltrexone—Syncope—Prednisone—ulcerative colitis	0.000124	0.000404	CcSEcCtD
Naltrexone—Anorexia—Dexamethasone—ulcerative colitis	0.000124	0.000403	CcSEcCtD
Naltrexone—Anorexia—Betamethasone—ulcerative colitis	0.000124	0.000403	CcSEcCtD
Naltrexone—Urticaria—Prednisolone—ulcerative colitis	0.000123	0.000402	CcSEcCtD
Naltrexone—OPRM1—TCR Signaling Pathway—NFKB1—ulcerative colitis	0.000123	0.00263	CbGpPWpGaD
Naltrexone—Fatigue—Triamcinolone—ulcerative colitis	0.000123	0.000402	CcSEcCtD
Naltrexone—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000123	0.00262	CbGpPWpGaD
Naltrexone—Fatigue—Methylprednisolone—ulcerative colitis	0.000123	0.000401	CcSEcCtD
Naltrexone—Pain—Triamcinolone—ulcerative colitis	0.000122	0.000398	CcSEcCtD
Naltrexone—Loss of consciousness—Prednisone—ulcerative colitis	0.000122	0.000396	CcSEcCtD
Naltrexone—Urticaria—Hydrocortisone—ulcerative colitis	0.00012	0.000393	CcSEcCtD
Naltrexone—OPRM1—GPCR ligand binding—CCR6—ulcerative colitis	0.00012	0.00257	CbGpPWpGaD
Naltrexone—Body temperature increased—Hydrocortisone—ulcerative colitis	0.00012	0.000391	CcSEcCtD
Naltrexone—Abdominal pain—Hydrocortisone—ulcerative colitis	0.00012	0.000391	CcSEcCtD
Naltrexone—Convulsion—Prednisone—ulcerative colitis	0.00012	0.000391	CcSEcCtD
Naltrexone—Hypertension—Prednisone—ulcerative colitis	0.000119	0.000389	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000118	0.000385	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000118	0.000385	CcSEcCtD
Naltrexone—Arthralgia—Prednisone—ulcerative colitis	0.000118	0.000384	CcSEcCtD
Naltrexone—Myalgia—Prednisone—ulcerative colitis	0.000118	0.000384	CcSEcCtD
Naltrexone—Feeling abnormal—Triamcinolone—ulcerative colitis	0.000118	0.000384	CcSEcCtD
Naltrexone—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.000117	0.000383	CcSEcCtD
Naltrexone—Anxiety—Prednisone—ulcerative colitis	0.000117	0.000383	CcSEcCtD
Naltrexone—Insomnia—Dexamethasone—ulcerative colitis	0.000117	0.000382	CcSEcCtD
Naltrexone—Insomnia—Betamethasone—ulcerative colitis	0.000117	0.000382	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000117	0.000381	CcSEcCtD
Naltrexone—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000117	0.00038	CcSEcCtD
Naltrexone—Paraesthesia—Dexamethasone—ulcerative colitis	0.000116	0.00038	CcSEcCtD
Naltrexone—Paraesthesia—Betamethasone—ulcerative colitis	0.000116	0.00038	CcSEcCtD
Naltrexone—Discomfort—Prednisone—ulcerative colitis	0.000116	0.000379	CcSEcCtD
Naltrexone—OPRK1—GPCR ligand binding—GHRL—ulcerative colitis	0.000115	0.00245	CbGpPWpGaD
Naltrexone—Hypersensitivity—Prednisolone—ulcerative colitis	0.000114	0.000373	CcSEcCtD
Naltrexone—Urticaria—Triamcinolone—ulcerative colitis	0.000113	0.00037	CcSEcCtD
Naltrexone—Urticaria—Methylprednisolone—ulcerative colitis	0.000113	0.000369	CcSEcCtD
Naltrexone—OPRD1—Signaling by GPCR—CXCR1—ulcerative colitis	0.000113	0.00242	CbGpPWpGaD
Naltrexone—Body temperature increased—Triamcinolone—ulcerative colitis	0.000113	0.000368	CcSEcCtD
Naltrexone—Oedema—Prednisone—ulcerative colitis	0.000113	0.000368	CcSEcCtD
Naltrexone—Anaphylactic shock—Prednisone—ulcerative colitis	0.000113	0.000368	CcSEcCtD
Naltrexone—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000113	0.000367	CcSEcCtD
Naltrexone—Decreased appetite—Betamethasone—ulcerative colitis	0.000113	0.000367	CcSEcCtD
Naltrexone—Decreased appetite—Dexamethasone—ulcerative colitis	0.000113	0.000367	CcSEcCtD
Naltrexone—OPRM1—G alpha (i) signalling events—ADCY5—ulcerative colitis	0.000112	0.0024	CbGpPWpGaD
Naltrexone—Infection—Prednisone—ulcerative colitis	0.000112	0.000366	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000112	0.000365	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000112	0.000365	CcSEcCtD
Naltrexone—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000112	0.000364	CcSEcCtD
Naltrexone—Fatigue—Betamethasone—ulcerative colitis	0.000112	0.000364	CcSEcCtD
Naltrexone—Fatigue—Dexamethasone—ulcerative colitis	0.000112	0.000364	CcSEcCtD
Naltrexone—Shock—Prednisone—ulcerative colitis	0.000111	0.000362	CcSEcCtD
Naltrexone—Pain—Dexamethasone—ulcerative colitis	0.000111	0.000361	CcSEcCtD
Naltrexone—Pain—Betamethasone—ulcerative colitis	0.000111	0.000361	CcSEcCtD
Naltrexone—Nervous system disorder—Prednisone—ulcerative colitis	0.000111	0.000361	CcSEcCtD
Naltrexone—Tachycardia—Prednisone—ulcerative colitis	0.00011	0.000359	CcSEcCtD
Naltrexone—Skin disorder—Prednisone—ulcerative colitis	0.00011	0.000358	CcSEcCtD
Naltrexone—OPRD1—GPCR downstream signaling—CCL20—ulcerative colitis	0.000109	0.00234	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000109	0.00233	CbGpPWpGaD
Naltrexone—Hyperhidrosis—Prednisone—ulcerative colitis	0.000109	0.000356	CcSEcCtD
Naltrexone—Asthenia—Hydrocortisone—ulcerative colitis	0.000109	0.000355	CcSEcCtD
Naltrexone—OPRD1—GPCR ligand binding—ADRB2—ulcerative colitis	0.000108	0.00231	CbGpPWpGaD
Naltrexone—Anorexia—Prednisone—ulcerative colitis	0.000108	0.000351	CcSEcCtD
Naltrexone—Pruritus—Hydrocortisone—ulcerative colitis	0.000107	0.00035	CcSEcCtD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	0.000107	0.00228	CbGpPWpGaD
Naltrexone—Feeling abnormal—Dexamethasone—ulcerative colitis	0.000107	0.000348	CcSEcCtD
Naltrexone—Feeling abnormal—Betamethasone—ulcerative colitis	0.000107	0.000348	CcSEcCtD
Naltrexone—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000106	0.000346	CcSEcCtD
Naltrexone—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000106	0.000346	CcSEcCtD
Naltrexone—OPRM1—GPCR ligand binding—PTGER4—ulcerative colitis	0.000106	0.00226	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—HLA-DRB1—ulcerative colitis	0.000106	0.00226	CbGpPWpGaD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.000105	0.00225	CbGpPWpGaD
Naltrexone—Hypersensitivity—Triamcinolone—ulcerative colitis	0.000105	0.000343	CcSEcCtD
Naltrexone—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.000105	0.000342	CcSEcCtD
Naltrexone—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000104	0.000338	CcSEcCtD
Naltrexone—Urticaria—Betamethasone—ulcerative colitis	0.000103	0.000336	CcSEcCtD
Naltrexone—Urticaria—Dexamethasone—ulcerative colitis	0.000103	0.000336	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Prednisone—ulcerative colitis	0.000103	0.000335	CcSEcCtD
Naltrexone—OPRD1—GPCR downstream signaling—GNA12—ulcerative colitis	0.000103	0.0022	CbGpPWpGaD
Naltrexone—OPRM1—TCR Signaling Pathway—TGFB1—ulcerative colitis	0.000103	0.00219	CbGpPWpGaD
Naltrexone—Dizziness—Prednisolone—ulcerative colitis	0.000103	0.000335	CcSEcCtD
Naltrexone—Asthenia—Triamcinolone—ulcerative colitis	0.000102	0.000334	CcSEcCtD
Naltrexone—Body temperature increased—Betamethasone—ulcerative colitis	0.000102	0.000334	CcSEcCtD
Naltrexone—Body temperature increased—Dexamethasone—ulcerative colitis	0.000102	0.000334	CcSEcCtD
Naltrexone—Abdominal pain—Dexamethasone—ulcerative colitis	0.000102	0.000334	CcSEcCtD
Naltrexone—Abdominal pain—Betamethasone—ulcerative colitis	0.000102	0.000334	CcSEcCtD
Naltrexone—OPRD1—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	0.000102	0.00218	CbGpPWpGaD
Naltrexone—Asthenia—Methylprednisolone—ulcerative colitis	0.000102	0.000333	CcSEcCtD
Naltrexone—Insomnia—Prednisone—ulcerative colitis	0.000102	0.000333	CcSEcCtD
Naltrexone—Paraesthesia—Prednisone—ulcerative colitis	0.000101	0.000331	CcSEcCtD
Naltrexone—Pruritus—Triamcinolone—ulcerative colitis	0.000101	0.00033	CcSEcCtD
Naltrexone—Pruritus—Methylprednisolone—ulcerative colitis	0.000101	0.000329	CcSEcCtD
Naltrexone—Dizziness—Hydrocortisone—ulcerative colitis	0.0001	0.000327	CcSEcCtD
Naltrexone—OPRD1—Signaling by GPCR—CCL20—ulcerative colitis	9.93e-05	0.00212	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—CXCR1—ulcerative colitis	9.92e-05	0.00212	CbGpPWpGaD
Naltrexone—Decreased appetite—Prednisone—ulcerative colitis	9.81e-05	0.00032	CcSEcCtD
Naltrexone—Rash—Prednisolone—ulcerative colitis	9.79e-05	0.000319	CcSEcCtD
Naltrexone—Dermatitis—Prednisolone—ulcerative colitis	9.78e-05	0.000319	CcSEcCtD
Naltrexone—Diarrhoea—Methylprednisolone—ulcerative colitis	9.75e-05	0.000318	CcSEcCtD
Naltrexone—OPRD1—GPCR downstream signaling—CXCR2—ulcerative colitis	9.74e-05	0.00208	CbGpPWpGaD
Naltrexone—Fatigue—Prednisone—ulcerative colitis	9.73e-05	0.000317	CcSEcCtD
Naltrexone—Headache—Prednisolone—ulcerative colitis	9.73e-05	0.000317	CcSEcCtD
Naltrexone—OPRM1—GPCR ligand binding—GHRL—ulcerative colitis	9.68e-05	0.00207	CbGpPWpGaD
Naltrexone—Constipation—Prednisone—ulcerative colitis	9.65e-05	0.000315	CcSEcCtD
Naltrexone—Vomiting—Hydrocortisone—ulcerative colitis	9.64e-05	0.000315	CcSEcCtD
Naltrexone—OPRK1—GPCR downstream signaling—CCL20—ulcerative colitis	9.59e-05	0.00205	CbGpPWpGaD
Naltrexone—Rash—Hydrocortisone—ulcerative colitis	9.56e-05	0.000312	CcSEcCtD
Naltrexone—Dermatitis—Hydrocortisone—ulcerative colitis	9.55e-05	0.000312	CcSEcCtD
Naltrexone—Headache—Hydrocortisone—ulcerative colitis	9.5e-05	0.00031	CcSEcCtD
Naltrexone—OPRK1—GPCR ligand binding—ADRB2—ulcerative colitis	9.49e-05	0.00203	CbGpPWpGaD
Naltrexone—Dizziness—Triamcinolone—ulcerative colitis	9.44e-05	0.000308	CcSEcCtD
Naltrexone—Dizziness—Methylprednisolone—ulcerative colitis	9.42e-05	0.000307	CcSEcCtD
Naltrexone—OPRD1—Signaling by GPCR—GNA12—ulcerative colitis	9.33e-05	0.00199	CbGpPWpGaD
Naltrexone—Feeling abnormal—Prednisone—ulcerative colitis	9.3e-05	0.000303	CcSEcCtD
Naltrexone—Asthenia—Dexamethasone—ulcerative colitis	9.3e-05	0.000303	CcSEcCtD
Naltrexone—Asthenia—Betamethasone—ulcerative colitis	9.3e-05	0.000303	CcSEcCtD
Naltrexone—UGT1A1—Metabolism—CHP1—ulcerative colitis	9.26e-05	0.00198	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—CXCR1—ulcerative colitis	9.23e-05	0.00197	CbGpPWpGaD
Naltrexone—Gastrointestinal pain—Prednisone—ulcerative colitis	9.23e-05	0.000301	CcSEcCtD
Naltrexone—Nausea—Prednisolone—ulcerative colitis	9.22e-05	0.000301	CcSEcCtD
Naltrexone—Pruritus—Betamethasone—ulcerative colitis	9.17e-05	0.000299	CcSEcCtD
Naltrexone—Pruritus—Dexamethasone—ulcerative colitis	9.17e-05	0.000299	CcSEcCtD
Naltrexone—OPRD1—GPCR downstream signaling—CCR6—ulcerative colitis	9.16e-05	0.00196	CbGpPWpGaD
Naltrexone—Vomiting—Triamcinolone—ulcerative colitis	9.08e-05	0.000296	CcSEcCtD
Naltrexone—Vomiting—Methylprednisolone—ulcerative colitis	9.06e-05	0.000296	CcSEcCtD
Naltrexone—OPRK1—GPCR downstream signaling—GNA12—ulcerative colitis	9.01e-05	0.00193	CbGpPWpGaD
Naltrexone—Nausea—Hydrocortisone—ulcerative colitis	9.01e-05	0.000294	CcSEcCtD
Naltrexone—Rash—Triamcinolone—ulcerative colitis	9e-05	0.000294	CcSEcCtD
Naltrexone—Dermatitis—Triamcinolone—ulcerative colitis	9e-05	0.000293	CcSEcCtD
Naltrexone—Rash—Methylprednisolone—ulcerative colitis	8.98e-05	0.000293	CcSEcCtD
Naltrexone—Dermatitis—Methylprednisolone—ulcerative colitis	8.98e-05	0.000293	CcSEcCtD
Naltrexone—OPRK1—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	8.97e-05	0.00192	CbGpPWpGaD
Naltrexone—Urticaria—Prednisone—ulcerative colitis	8.96e-05	0.000292	CcSEcCtD
Naltrexone—Headache—Triamcinolone—ulcerative colitis	8.95e-05	0.000292	CcSEcCtD
Naltrexone—Headache—Methylprednisolone—ulcerative colitis	8.93e-05	0.000291	CcSEcCtD
Naltrexone—Abdominal pain—Prednisone—ulcerative colitis	8.92e-05	0.000291	CcSEcCtD
Naltrexone—Body temperature increased—Prednisone—ulcerative colitis	8.92e-05	0.000291	CcSEcCtD
Naltrexone—Diarrhoea—Betamethasone—ulcerative colitis	8.87e-05	0.000289	CcSEcCtD
Naltrexone—Diarrhoea—Dexamethasone—ulcerative colitis	8.87e-05	0.000289	CcSEcCtD
Naltrexone—OPRD1—Signaling by GPCR—CXCR2—ulcerative colitis	8.85e-05	0.00189	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—CCL20—ulcerative colitis	8.71e-05	0.00186	CbGpPWpGaD
Naltrexone—OPRD1—G alpha (i) signalling events—CXCL8—ulcerative colitis	8.63e-05	0.00184	CbGpPWpGaD
Naltrexone—Dizziness—Betamethasone—ulcerative colitis	8.57e-05	0.00028	CcSEcCtD
Naltrexone—Dizziness—Dexamethasone—ulcerative colitis	8.57e-05	0.00028	CcSEcCtD
Naltrexone—OPRK1—GPCR downstream signaling—CXCR2—ulcerative colitis	8.55e-05	0.00183	CbGpPWpGaD
Naltrexone—Nausea—Triamcinolone—ulcerative colitis	8.48e-05	0.000277	CcSEcCtD
Naltrexone—Nausea—Methylprednisolone—ulcerative colitis	8.46e-05	0.000276	CcSEcCtD
Naltrexone—OPRM1—Signaling by GPCR—CXCR1—ulcerative colitis	8.38e-05	0.00179	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—CCR6—ulcerative colitis	8.32e-05	0.00178	CbGpPWpGaD
Naltrexone—Hypersensitivity—Prednisone—ulcerative colitis	8.31e-05	0.000271	CcSEcCtD
Naltrexone—Vomiting—Dexamethasone—ulcerative colitis	8.24e-05	0.000269	CcSEcCtD
Naltrexone—Vomiting—Betamethasone—ulcerative colitis	8.24e-05	0.000269	CcSEcCtD
Naltrexone—OPRK1—Signaling by GPCR—GNA12—ulcerative colitis	8.19e-05	0.00175	CbGpPWpGaD
Naltrexone—Rash—Dexamethasone—ulcerative colitis	8.17e-05	0.000267	CcSEcCtD
Naltrexone—Rash—Betamethasone—ulcerative colitis	8.17e-05	0.000267	CcSEcCtD
Naltrexone—Dermatitis—Dexamethasone—ulcerative colitis	8.16e-05	0.000266	CcSEcCtD
Naltrexone—Dermatitis—Betamethasone—ulcerative colitis	8.16e-05	0.000266	CcSEcCtD
Naltrexone—Headache—Dexamethasone—ulcerative colitis	8.12e-05	0.000265	CcSEcCtD
Naltrexone—Headache—Betamethasone—ulcerative colitis	8.12e-05	0.000265	CcSEcCtD
Naltrexone—OPRD1—Signaling Pathways—SEL1L—ulcerative colitis	8.11e-05	0.00173	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—CCL20—ulcerative colitis	8.1e-05	0.00173	CbGpPWpGaD
Naltrexone—Asthenia—Prednisone—ulcerative colitis	8.1e-05	0.000264	CcSEcCtD
Naltrexone—OPRD1—GPCR downstream signaling—PTGER4—ulcerative colitis	8.07e-05	0.00172	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—CCR6—ulcerative colitis	8.03e-05	0.00172	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—ADRB2—ulcerative colitis	8.02e-05	0.00171	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—DLD—ulcerative colitis	7.99e-05	0.00171	CbGpPWpGaD
Naltrexone—Pruritus—Prednisone—ulcerative colitis	7.98e-05	0.00026	CcSEcCtD
Naltrexone—OPRK1—Signaling by GPCR—CXCR2—ulcerative colitis	7.76e-05	0.00166	CbGpPWpGaD
Naltrexone—OPRM1—TCR Signaling Pathway—IL6—ulcerative colitis	7.74e-05	0.00165	CbGpPWpGaD
Naltrexone—Diarrhoea—Prednisone—ulcerative colitis	7.72e-05	0.000252	CcSEcCtD
Naltrexone—ABCB1—Allograft Rejection—IFNG—ulcerative colitis	7.72e-05	0.00165	CbGpPWpGaD
Naltrexone—Nausea—Dexamethasone—ulcerative colitis	7.7e-05	0.000251	CcSEcCtD
Naltrexone—Nausea—Betamethasone—ulcerative colitis	7.7e-05	0.000251	CcSEcCtD
Naltrexone—OPRM1—GPCR downstream signaling—GNA12—ulcerative colitis	7.62e-05	0.00163	CbGpPWpGaD
Naltrexone—OPRM1—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	7.58e-05	0.00162	CbGpPWpGaD
Naltrexone—OPRK1—G alpha (i) signalling events—CXCL8—ulcerative colitis	7.57e-05	0.00162	CbGpPWpGaD
Naltrexone—Dizziness—Prednisone—ulcerative colitis	7.46e-05	0.000243	CcSEcCtD
Naltrexone—ABCB1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	7.39e-05	0.00158	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	7.39e-05	0.00158	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—GHRL—ulcerative colitis	7.39e-05	0.00158	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CCL20—ulcerative colitis	7.36e-05	0.00157	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—PTGER4—ulcerative colitis	7.33e-05	0.00156	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—CCR6—ulcerative colitis	7.3e-05	0.00156	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—CXCR2—ulcerative colitis	7.22e-05	0.00154	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—CXCL8—ulcerative colitis	7.18e-05	0.00153	CbGpPWpGaD
Naltrexone—Vomiting—Prednisone—ulcerative colitis	7.17e-05	0.000234	CcSEcCtD
Naltrexone—UGT1A1—NRF2 pathway—TGFB1—ulcerative colitis	7.13e-05	0.00152	CbGpPWpGaD
Naltrexone—Rash—Prednisone—ulcerative colitis	7.11e-05	0.000232	CcSEcCtD
Naltrexone—OPRK1—Signaling Pathways—SEL1L—ulcerative colitis	7.11e-05	0.00152	CbGpPWpGaD
Naltrexone—Dermatitis—Prednisone—ulcerative colitis	7.11e-05	0.000232	CcSEcCtD
Naltrexone—OPRK1—GPCR downstream signaling—PTGER4—ulcerative colitis	7.07e-05	0.00151	CbGpPWpGaD
Naltrexone—Headache—Prednisone—ulcerative colitis	7.07e-05	0.000231	CcSEcCtD
Naltrexone—OPRM1—Signaling by GPCR—GNA12—ulcerative colitis	6.92e-05	0.00148	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—IL1B—ulcerative colitis	6.88e-05	0.00147	CbGpPWpGaD
Naltrexone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	6.86e-05	0.00147	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—IL2—ulcerative colitis	6.86e-05	0.00146	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—CCR6—ulcerative colitis	6.79e-05	0.00145	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—GHRL—ulcerative colitis	6.71e-05	0.00143	CbGpPWpGaD
Naltrexone—Nausea—Prednisone—ulcerative colitis	6.7e-05	0.000219	CcSEcCtD
Naltrexone—OPRD1—Signaling Pathways—CXCR1—ulcerative colitis	6.68e-05	0.00143	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CXCR2—ulcerative colitis	6.56e-05	0.0014	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—CALM3—ulcerative colitis	6.5e-05	0.00139	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—GHRL—ulcerative colitis	6.48e-05	0.00138	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—PTGER4—ulcerative colitis	6.42e-05	0.00137	CbGpPWpGaD
Naltrexone—OPRM1—G alpha (i) signalling events—CXCL8—ulcerative colitis	6.39e-05	0.00137	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CCR6—ulcerative colitis	6.17e-05	0.00132	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—ADRB2—ulcerative colitis	6.11e-05	0.00131	CbGpPWpGaD
Naltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	6.02e-05	0.00129	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—SEL1L—ulcerative colitis	6.01e-05	0.00128	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—PTGER4—ulcerative colitis	5.98e-05	0.00128	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—GHRL—ulcerative colitis	5.88e-05	0.00126	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CCL20—ulcerative colitis	5.87e-05	0.00125	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CXCR1—ulcerative colitis	5.86e-05	0.00125	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—CALM3—ulcerative colitis	5.7e-05	0.00122	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—ADRB2—ulcerative colitis	5.55e-05	0.00119	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—GNA12—ulcerative colitis	5.51e-05	0.00118	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—GHRL—ulcerative colitis	5.47e-05	0.00117	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—PTGER4—ulcerative colitis	5.43e-05	0.00116	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—ADRB2—ulcerative colitis	5.36e-05	0.00115	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	5.35e-05	0.00114	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CXCR2—ulcerative colitis	5.23e-05	0.00112	CbGpPWpGaD
Naltrexone—OPRD1—GPCR ligand binding—CXCL8—ulcerative colitis	5.22e-05	0.00112	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—ADCY5—ulcerative colitis	5.19e-05	0.00111	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CCL20—ulcerative colitis	5.14e-05	0.0011	CbGpPWpGaD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	5.08e-05	0.00109	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—TNF—ulcerative colitis	4.99e-05	0.00107	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—GHRL—ulcerative colitis	4.97e-05	0.00106	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CXCR1—ulcerative colitis	4.95e-05	0.00106	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CCR6—ulcerative colitis	4.92e-05	0.00105	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—ADRB2—ulcerative colitis	4.87e-05	0.00104	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—GNA12—ulcerative colitis	4.84e-05	0.00103	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CALM3—ulcerative colitis	4.81e-05	0.00103	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—ADCY5—ulcerative colitis	4.71e-05	0.00101	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—MAML2—ulcerative colitis	4.66e-05	0.000995	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	4.6e-05	0.000983	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CXCR2—ulcerative colitis	4.58e-05	0.000979	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—CXCL8—ulcerative colitis	4.58e-05	0.000979	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—ADCY5—ulcerative colitis	4.55e-05	0.000972	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—ADRB2—ulcerative colitis	4.53e-05	0.000968	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CCL20—ulcerative colitis	4.35e-05	0.000928	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—PTGER4—ulcerative colitis	4.33e-05	0.000924	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CCR6—ulcerative colitis	4.31e-05	0.000921	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CHP1—ulcerative colitis	4.25e-05	0.000907	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—ADCY5—ulcerative colitis	4.13e-05	0.000883	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—ADRB2—ulcerative colitis	4.11e-05	0.000879	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—GNA12—ulcerative colitis	4.09e-05	0.000873	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—MAML2—ulcerative colitis	4.09e-05	0.000873	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—GHRL—ulcerative colitis	3.96e-05	0.000846	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CXCR2—ulcerative colitis	3.87e-05	0.000828	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—CXCL8—ulcerative colitis	3.87e-05	0.000827	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—PTGS1—ulcerative colitis	3.86e-05	0.000825	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—ADCY5—ulcerative colitis	3.85e-05	0.000821	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CALM3—ulcerative colitis	3.84e-05	0.00082	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—PTGER4—ulcerative colitis	3.79e-05	0.000811	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—RIPK2—ulcerative colitis	3.78e-05	0.000807	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—DLD—ulcerative colitis	3.67e-05	0.000783	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	3.65e-05	0.00078	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CCR6—ulcerative colitis	3.64e-05	0.000778	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—ADCY5—ulcerative colitis	3.49e-05	0.000746	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—CALM3—ulcerative colitis	3.48e-05	0.000743	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—GHRL—ulcerative colitis	3.47e-05	0.000742	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—MAML2—ulcerative colitis	3.45e-05	0.000738	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CALM3—ulcerative colitis	3.36e-05	0.000719	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—RIPK2—ulcerative colitis	3.31e-05	0.000708	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—ADRB2—ulcerative colitis	3.28e-05	0.000701	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—JAK2—ulcerative colitis	3.23e-05	0.000691	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PTGER4—ulcerative colitis	3.21e-05	0.000685	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	3.17e-05	0.000677	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—CXCL8—ulcerative colitis	2.95e-05	0.000631	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—JAK2—ulcerative colitis	2.94e-05	0.000628	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—GHRL—ulcerative colitis	2.94e-05	0.000627	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—ADRB2—ulcerative colitis	2.88e-05	0.000614	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CALM3—ulcerative colitis	2.84e-05	0.000607	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—JAK2—ulcerative colitis	2.84e-05	0.000606	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—IL2—ulcerative colitis	2.82e-05	0.000603	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—RIPK2—ulcerative colitis	2.8e-05	0.000598	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—ADCY5—ulcerative colitis	2.78e-05	0.000595	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—ABCB1—ulcerative colitis	2.7e-05	0.000578	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—CXCL8—ulcerative colitis	2.68e-05	0.000573	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	2.64e-05	0.000564	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—CXCL8—ulcerative colitis	2.59e-05	0.000553	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—JAK2—ulcerative colitis	2.58e-05	0.00055	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—IL2—ulcerative colitis	2.56e-05	0.000547	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—ADCY5—ulcerative colitis	2.52e-05	0.000539	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—IL2—ulcerative colitis	2.47e-05	0.000529	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	2.47e-05	0.000528	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	2.46e-05	0.000527	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—ADCY5—ulcerative colitis	2.44e-05	0.000521	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—ADRB2—ulcerative colitis	2.43e-05	0.000519	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—JAK2—ulcerative colitis	2.4e-05	0.000512	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—CXCL8—ulcerative colitis	2.35e-05	0.000502	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—IL2—ulcerative colitis	2.25e-05	0.00048	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—CXCL8—ulcerative colitis	2.19e-05	0.000467	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—JAK2—ulcerative colitis	2.18e-05	0.000465	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	2.17e-05	0.000464	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—IL2—ulcerative colitis	2.09e-05	0.000447	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—ADCY5—ulcerative colitis	2.06e-05	0.000441	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CXCL8—ulcerative colitis	1.99e-05	0.000424	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—IL2—ulcerative colitis	1.9e-05	0.000406	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—PPARG—ulcerative colitis	1.88e-05	0.000402	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—PTGS1—ulcerative colitis	1.77e-05	0.000378	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—JAK2—ulcerative colitis	1.74e-05	0.000371	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—ALB—ulcerative colitis	1.69e-05	0.000361	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—RELA—ulcerative colitis	1.68e-05	0.000359	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.66e-05	0.000354	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CALM3—ulcerative colitis	1.6e-05	0.000341	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CXCL8—ulcerative colitis	1.58e-05	0.000338	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—JAK2—ulcerative colitis	1.52e-05	0.000325	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—IL2—ulcerative colitis	1.51e-05	0.000323	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—IL6—ulcerative colitis	1.51e-05	0.000322	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—PTGS2—ulcerative colitis	1.48e-05	0.000316	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—RELA—ulcerative colitis	1.47e-05	0.000315	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—MMP9—ulcerative colitis	1.43e-05	0.000306	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—NFKB1—ulcerative colitis	1.42e-05	0.000303	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CXCL8—ulcerative colitis	1.39e-05	0.000297	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—IL2—ulcerative colitis	1.33e-05	0.000284	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—IL6—ulcerative colitis	1.32e-05	0.000282	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—JAK2—ulcerative colitis	1.29e-05	0.000275	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—STAT3—ulcerative colitis	1.27e-05	0.000272	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—MMP9—ulcerative colitis	1.26e-05	0.000268	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—RELA—ulcerative colitis	1.25e-05	0.000266	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—NFKB1—ulcerative colitis	1.24e-05	0.000265	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—TGFB1—ulcerative colitis	1.18e-05	0.000252	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CXCL8—ulcerative colitis	1.17e-05	0.000251	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ADCY5—ulcerative colitis	1.16e-05	0.000247	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IL2—ulcerative colitis	1.12e-05	0.00024	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—STAT3—ulcerative colitis	1.12e-05	0.000239	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—IL6—ulcerative colitis	1.12e-05	0.000238	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—MMP9—ulcerative colitis	1.06e-05	0.000227	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—NFKB1—ulcerative colitis	1.05e-05	0.000224	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—TGFB1—ulcerative colitis	1.04e-05	0.000221	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—TP53—ulcerative colitis	9.72e-06	0.000208	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—STAT3—ulcerative colitis	9.44e-06	0.000202	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—IL6—ulcerative colitis	8.9e-06	0.00019	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—TGFB1—ulcerative colitis	8.75e-06	0.000187	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—PPARG—ulcerative colitis	8.63e-06	0.000184	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—TP53—ulcerative colitis	8.52e-06	0.000182	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—IL6—ulcerative colitis	7.8e-06	0.000167	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ALB—ulcerative colitis	7.76e-06	0.000166	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—TP53—ulcerative colitis	7.2e-06	0.000154	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—PTGS2—ulcerative colitis	6.79e-06	0.000145	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IL6—ulcerative colitis	6.59e-06	0.000141	CbGpPWpGaD
